Decision Support in Virginia

RIVANNA Medical develops AI-automated clinical decision support platforms for spinal needle intervention guidance and musculoskeletal diagnostics at the point of care. The company's proprietary technology combines deep learning algorithms trained on proprietary clinical datasets with advanced 3D ultrasound transducer technology to reduce operator variability and accelerate clinical decision-making in emergency medicine and anesthesia applications. Core product offerings include the Accuro 3S Needle Guide Kit (FDA 510(k) cleared as of December 2025) for neuraxial anesthesia procedures, and an AI-powered fracture triage platform for emergency department point-of-care imaging. Both products leverage RIVANNA's unified AI imaging architecture, which integrates SafeTrack™ needle tracking technology, Dual-Array™ multi-angle probe technology, and 3D volumetric imaging capabilities. The platforms feature portable bedside deployment, automated acquisition with minimal training dependency, real-time needle tip positioning overlays, and seamless EMR and DICOM integration with cloud connectivity for fleet analytics. The company addresses critical healthcare delivery gaps: ~70% of extremity fracture cases in emergency departments are rule-outs, yet patients wait hours for radiology confirmation; neuraxial anesthesia procedures relying on landmark palpation exhibit 38% first-attempt failure rates in challenging anatomies. RIVANNA's platforms target a combined total addressable market of $3.4B+ across neuraxial guidance ($1.9B) and fracture care ($1.5B). Validation includes NIH federal support, 8 clinical sites with 1,200+ enrolled subjects, peer-reviewed publication in Journal of Emergency Medicine (2026), and $3 million CDMRP grant award for military-optimized ultrasound guidance systems. The company holds 48 global patents and patents pending. Regulatory pathway includes FDA 510(k) clearance for Accuro 3S consumables, with SafeTrack™ needle tracking and fracture platform submissions pending. ICD-10-PCS coding is pending; CPT pathway validation is underway with major medical societies.

Medicomp Systems is a clinical AI software company founded in 1978, specializing in evidence-based clinical intelligence solutions for healthcare providers and technology partners. The company's flagship Quippe suite delivers a clinically intelligent data platform built on the MEDCIN clinical knowledge foundation, transforming unstructured clinical data into actionable insights at the point of care. Quippe integrates with EHRs and health IT systems to improve documentation efficiency, clinical decision-making, coding accuracy, and care compliance. The platform features deterministic clinical reasoning engines, universal clinical data standardization, and extensive clinical knowledge graphs mapping diagnostic relationships across symptoms, patient history, physical exams, genomics, tests, medications, and treatments. Medicomp's solutions enable healthcare organizations and software developers to embed sophisticated clinical understanding into their systems while reducing documentation burden and improving clinician satisfaction. The company collaborates with leading medical institutions to continuously validate its clinical knowledge base, ensuring tools meet real-world provider and patient needs.

Medical Decision Network (MDN) provides comprehensive healthcare software solutions focused on improving critical care quality and outcomes. The company specializes in ICU performance analytics, glycemic control management, and predictive severity modeling. MDN's flagship products include GlucoStabilizer®, an FDA-cleared IV insulin dosing system that automates glucose management and reduces hypoglycemia risk in hospitalized patients, and MDN PHOENIX, a critical care software platform featuring ACUITY 2019 predictive modeling for severity-adjusted outcome measurement. ACUITY 2019 delivers fully automated severity scoring with observed/expected calculations for length of stay, hospital mortality, and mechanical ventilation duration predictions—eliminating manual data collection while improving upon legacy APACHE models. ICUTracker® provides outcomes reporting and ICU performance benchmarking capabilities. These solutions enable hospitals to optimize clinical workflows, reduce glycemic variability complications, and drive data-driven process improvements across critical care units.